Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga October 29, 2014 at 08:12 AM EDT Cara Therapeutics (NASDAQ: CARA) shares jumped 14.45% to $9.90 in pre-market trading after the company announced positive results from ... Read More >> Related Stocks: Cara Therapeutics Regulus Therapeutics